Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.31 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL9935686 | 0.87 | SLC22A1 (0.46) | TSHRALDH1A1ZDHHC20ZDHHC2DNM1 | |
| SCHEMBL9935791 | 0.84 | SLC22A1 (0.38) | TSHRALDH1A1ZDHHC20ZDHHC2DNM1 | |
| SCHEMBL9934681 | 0.84 | DNM1 (0.42) | TSHRALDH1A1ZDHHC20ZDHHC2DNM1 | |
| Tributylmethylammonium SCHEMBL9935355 | 0.82 | TSHR (0.39) | ENPP2TSHRALDH1A1 | |
| SCHEMBL9934338 | 0.82 | DNM1 (0.52) | ENPP2TSHRDNM1 | |
| SCHEMBL9935057 | 0.82 | DNM1 (0.52) | ENPP2TSHRDNM1 | |
| Pentadecane SCHEMBL27822400 | 0.82 | TSHR (0.46) | TSHRALDH1A1ZDHHC20ZDHHC2 | |
| Tributylmethylammonium SCHEMBL9936098 | 0.81 | BBOX1 (0.36) | TSHRALDH1A1DNM1SLC22A1 | |
| SCHEMBL9935875 | 0.80 | — | — | |
| Tributylmethylammonium SCHEMBL9935588 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | ENPP2 1623/4885TSHR 2384/4885ALDH1A1 3717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.